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Mice with altered a-actinin-4 expression have distinct
morphologic patterns of glomerular disease
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Mutations in ACTN4, encoding the actin-binding protein
a-actinin-4, cause a form of familial focal segmental
glomerulosclerosis. We had developed two strains of
transgenic mice with distinct alterations in the expression of
a-actinin-4. One strain carried a human disease-associated
mutation in murine Actn4, whereas the other knockout strain
did not express a-actinin-4 protein. Most adult homozygous
Actn4 mutant and knockout mice developed collapsing
glomerulopathy. Homozygous Actn4 mutant mice also
exhibited actin and a-actinin-4-containing electron-dense
cytoplasmic structures, that were present but less prominent
in heterozygous Actn4 mutant mice and not consistently seen
in wild-type or knockout mice. Heterozygous Actn4 mutant
mice did not develop glomerulosclerosis, but did exhibit focal
glomerular hypertrophy and mild glomerular ultrastructural
changes. The ultrastructural abnormalities seen in
heterozygous Actn4 mutant mice suggest low-level
glomerular damage, which may increase susceptibility to
injury caused by genetic or environmental stressors. Our
studies show that different genetic defects in the same
protein produce a spectrum of glomerular morphologic
lesions depending on the specific combination of normal
and/or defective alleles.
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Mutations in ACTN4, the gene encoding the actin-binding
protein a-actinin-4, can cause familial focal segmental
glomerulosclerosis in humans.1 This familial form of familial
focal segmental glomerulosclerosis exhibits autosomal-domi-
nant transmission and is highly, but not fully, penetrant.
Individuals heterozygous for these mutations exhibit slowly
progressive disease that often results in kidney failure.
Morphologic changes in the kidney are typical of familial
focal segmental glomerulosclerosis and include segmental
podocyte foot process (FP) effacement.1
To study the role of a-actinin-4 protein in normal
podocyte function and genetic disease in vivo, we developed
two strains of transgenic mice with distinct alterations in the
expression of a-actinin-4. One strain carries a specific
mutation in the murine Actn4 gene encoding a-actinin-4,
corresponding to the K255E disease-associated mutation in
humans.2 The other strain exhibits complete absence of
measurable a-actinin-4 expression.3 Animals homozygous
for either of these altered Actn4 genotypes develop a rapidly
progressive kidney disease phenotype characterized by
increased perinatal lethality, severe glomerular disease, kidney
failure, and death in approximately 12 weeks. The resulting
disease phenotype in these homozygous mice is more
aggressive than the heterozygous human disease, and the
absence of normal a-actinin-4 protein in these mice suggests
a distinct disease mechanism. Therefore, one objective of this
study was to better characterize the morphologic pattern of
kidney disease observed in these transgenic animals, so as to
enhance our understanding of glomerular disease developing
in the absence of wild-type a-actinin-4.
The heterozygous Actn4 mutant animal represents a more
genetically faithful model of the autosomal-dominant
ACTN4-mediated human disease, as this animal expresses
both wild-type and mutant a-actinin-4. Initial studies of
young heterozygous Actn4 mutant mice did not reveal a
kidney disease phenotype. This is not inconsistent with the
human disease, as the first manifestations of kidney damage
in humans are not apparent until early adulthood.1 However,
a transgenic animal developed by Michaud et al.,4 which
expresses both endogenous wild-type and a K256E-mutant
a-actinin-4 transgene showed focal glomerulosclerosis
developing at approximately 10 weeks. As humans with
(heterozygous) ACTN4 mutations develop kidney disease
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later in life, it is plausible that heterozygous Actn4 mutant
mice may also not develop overt kidney disease until later in
life. Therefore, another objective of this study was to examine
the kidneys of older mice, heterozygous for the Actn4 mutant
allele, to look for features of slowly developing glomerular
disease that were not apparent in younger mice.
RESULTS
Light microscopic findings
Kidneys from 23 wild-type (WT), 17 heterozygous Actn4
K256E mutant (HET), 12 homozygous Actn4 K256E mutant
(KI), and 18 homozygous Actn4 null (KO) mice, age range
1–60 weeks, were evaluated by light microscopy. Only WT
and HET mice were available at later time points; KI and KO
mice did not survive past 21 and 15 weeks, respectively.
No significant morphologic changes were seen among
juvenile (age 0–7 weeks) or young adult (age 7–21 weeks) WT
mice (Figures 1 and 2a, b). Examination of kidneys from old
adult (age 421 weeks) WT mice revealed minimal focal
glomerular hypertrophy, but no other glomerular lesions
(Figure 1). HET mice showed no evidence of overt
glomerular injury, but did show focal glomerular hypertro-
phy at all ages, occasionally accompanied by focal hyaline cast
formation in the tubules, or focal interstitial inflammation
(Figures 1 and 2c, d).
Glomerular injury (segmental or global sclerosis or
collapse) was observed in 4 of 12 KI mice as early as 5.4
weeks, including 1 of 6 juvenile mice, and 3 of 6 young adult
mice. Similarly, 9 of 18 KO mice showed glomerular injury as
early as 3.7 weeks, including 4 of 12 juvenile and 5 of 6 young
adult mice. Among the homozygous mice not showing overt
glomerular injury, 5 of 8 KI mice and 2 of 9 KO mice
(including all young adult KI and KO mice) showed focal
glomerular hypertrophy involving a small proportion of
glomeruli, beginning as early as 4.4 and 3.4 weeks,
respectively (Figure 2e, g). Three juvenile KI mice and seven
juvenile KO mice showed no glomerular lesions. Averaged
over all mice in each category, 2.2 and 52.3% of glomeruli in
juvenile and young adult KI mice, respectively, and 15.7 and
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Figure 1 | Glomerular lesional involvement and distribution by
morphologic pattern of injury in Actn4 transgenic mice. Data are
categorized into juvenile (0–7 weeks), young adult (7–21 weeks), and
old adult (421 weeks) age groups. Genotypes indicated by WT (wild
type), HET (heterozygous Actn4 K256E mutant), KI (homozygous
Actn4 K256E mutant), and KO (homozygous Actn4 null). Height of
bars and bar segments indicates mean percentage of glomeruli
involved by lesions among all specimens examined within a specified
genotype and age group combination. Shading indicates specific
morphologic pattern of glomerular lesion. Number of specimens per
age group-genotype combination (n) also indicated. Juvenile KI mice
exhibited rare collapsing lesions involving 0.1% of glomeruli (data not
shown in figure).
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Figure 2 | Kidney histology in juvenile and young adult Actn4
transgenic mice. Wild-type (WT) mice aged 6 weeks (a) and 14
weeks (b) showing normal kidney histology. Heterozygous Actn4
K256E mutant (KI) mice aged 4 weeks (c) exhibiting normal kidney
histology and aged 14 weeks (d) showing focal glomerular
hypertrophy (arrow). Homozygous Actn4 K256E mutant (KI) mice
aged 4 weeks (e) showing focal glomerular hypertrophy and aged 14
weeks (f) showing focal global (arrowhead) and segmental (arrow)
glomerulosclerosis, mesangial expansion, extensive tubulointerstitial
damage, and tubular microcysts (asterisks). Rare collapsing lesions
(data not shown) were also observed in this specimen but were not
the predominant glomerular lesion. Homozygous Actn4 null (KO)
mice aged 4 weeks (g) showing focal glomerular hypertrophy and
aged 10 weeks (h) showing focal global (arrowheads)
glomerulosclerosis, glomerular capillary collapse and hyalinosis,
mesangial expansion, and epithelial proliferation (arrow), as well as
extensive tubulointerstitial damage including tubular microcyst
formation (asterisks). PAS stain. Bar¼ 100 mm in all images.
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70.4% of glomeruli in juvenile and young adult KO mice,
respectively, showed some form of glomerular lesion
(Figure 1).
Of the homozygous mice exhibiting overt glomerular
injury, 4 of 4 KI mice (youngest 5.4 weeks) and 8 of 9 KO
mice (youngest 3.7 weeks) showed a histologic pattern
of collapsing glomerulopathy. Features of collapsing
glomerulopathy included focal glomerular lesions composed
of segmental or global glomerular capillary collapse and
epithelial cell proliferation, focally prominent protein
reabsorption granules in glomerular and tubular epithelial
cells, and tubular ‘microcysts’ (Figures 2f, h and 3). One KO
mouse (6.7 weeks) exhibited diffuse segmental and global
glomerulosclerosis, but without collapsing lesions. Within
age groups, collapsing lesions involved a greater proportion
of glomeruli in KO mice than in KI mice. Averaged over all
mice in each category, glomerular collapsing lesions involved
0.1 and 7.0% of glomeruli in juvenile and young adult KI
mice, respectively, and 4.7 and 26.9% of glomeruli in
juvenile and young adult KO mice, respectively (Figure 1).
Homozygous mice also showed a varying degree of segmental
and global glomerulosclerosis in addition to the collapsing
lesions. Averaged over all mice in each category, sclerosing
lesions (segmental or global) in KO mice involved 10.6% of
glomeruli in juveniles and 43.1% of glomeruli in young
adults (Figure 1). In KI mice, no sclerosing lesions were seen
in juveniles, whereas 43.4% of glomeruli in young adults
exhibited sclerosing lesions (Figure 1).
Kidneys with evidence of glomerular injury also exhibited
a proportional degree of tubulointerstitial damage (Figure 2f,
h). The tubulointerstitial damage was characterized by
mononuclear interstitial inflammation and features of acute
tubular injury (for example, epithelial flattening, loss of
brush border, cytoplasmic vacuolization, and rare mitotic
figures). Prominent tubular microcyst formation was noted
in all homozygous KO kidneys where collapsing lesions were
identified, as well as in the previously noted 6.7-week
homozygous KO animal with diffuse global and segmental
glomerulosclerosis, which did not show collapsing lesions.
Microcysts were not as prominent in the homozygous KI
mice and were only observed in 2 of 4 specimens with
collapsing lesions. Hyaline casts were seen in almost all
homozygous specimens with glomerular damage. Chronic
tubulointerstitial changes (advanced tubular atrophy and
interstitial fibrosis) were a minor feature of the tubulointer-
stitial damage, even in cases with advanced glomerular
disease. No significant vascular lesions were observed in any
animals.
Ultrastructural findings
A total of 18 WT, 21 HET, 12 KI, and 17 KO animals, ranging
in age from 1 to 93 weeks, were evaluated at the
ultrastructural level. Of the WT animals, 8 of 18 showed no
ultrastructural abnormalities (Figures 4 and 5a, b). However,
8 of 18 showed mild glomerular basement membrane (GBM)
abnormalities as early as 6.3 weeks, but most commonly
in adult animals (Figures 4a and 5c). GBM abnormalities
consisted of segmental areas of subepithelial thickening
and redundancy, often protruding from the subepithelial
surface of the GBM. A smaller subset of WT animals (5 of 18)
revealed mild podocyte FP abnormalities (Figure 4b).
Notably, one of the WT mice showing mild FP abnormalities
was the youngest mouse in this group (age 1.4 weeks). Only
one older adult WT animal (60 weeks) showed mild podocyte
cell body (PCB) abnormalities (Figure 4c).
HET animals showed a pattern of ultrastructural findings
similar to WT animals, but abnormalities were somewhat
more severe, and affected a greater proportion of animals
(Figures 4 and 5d–f). The GBM in 15 of 21 HET animals,
including 13 of 14 adults, showed mild-to-moderate
abnormalities, again characterized by segmental subepithelial
thickening and redundancy (Figures 4a and 5e, f). FP in HET
animals were mildly but almost uniformly abnormal; 16 of 21
animals including all adults showed segmental effacement
and morphologic irregularity (Figures 4b and 5e, f). The
difference in mean FP abnormality scores between WT
and HET mice was statistically significant for both the
young adult (P¼ 0.05) and older adult (P¼ 0.01) cohorts
a b
c d
Figure 3 | Features of glomerular collapsing lesions in
homozygous Actn4 transgenic mice. (a, b) Homozygous Actn4 null
(KO) mouse aged 6 weeks. (a) Glomerular collapsing lesions with
glomerular epithelial proliferation and no inflammation; a mitotic
figure is evident among the proliferating epithelial cells in one of the
glomeruli (arrow). (b) Glomerular collapsing lesion with focal
accumulation of PAS-positive protein reabsorption granules
in proliferating glomerular epithelial cells (arrowheads).
(c, d) Homozygous Actn4 K256E mutant (KI) mouse aged 14 weeks.
(c) Glomerular collapsing lesions with prominent glomerular
epithelial proliferation. (d) Focally prominent PAS-positive protein
reabsorption granules in epithelial cells (arrowheads) of a lesional
glomerulus. PAS stain. Bar¼ 50mm in all images.
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(Figure 4b). PCB also exhibited mild ultrastructural
abnormalities in 12 of 21 HET animals (Figures 4c and 5e,
f). The difference in mean PCB abnormality scores between
the WT and HET mice in the older adult cohort was also
statistically significant (P¼ 0.03) (Figure 4c).
Nearly all KI mice (11 of 12), with the exception of the
youngest KI mouse evaluated at the ultrastructural level (2.1
weeks), showed GBM abnormalities. These changes were
mild in the juvenile KI mice, but were moderate to severe in
the adult KI mice, and again consisted of segmental
subepithelial thickening and redundancy, often with numer-
ous protrusions (Figures 4a and 5g, h). The difference in
mean GBM abnormality scores between WT and KI mice was
statistically significant for both juvenile (P¼ 0.03) and young
adult (P¼ 0.01) cohorts (Figure 4a). Podocytes in almost all
KI mice (11 of 12), again except for the youngest (2.1 weeks)
mouse, exhibited progressive degenerative changes that are
characteristic of primary podocyte injury, including FP and
PCB abnormalities (Figure 5g, h). Juvenile KI mice showed a
variable but overall mild degree of podocyte degenerative
changes, first detected at 4 weeks, whereas all young adult KI
mice showed more severe changes (Figure 4b, c). The
difference in both mean FP and PCB abnormality scores
between WT and KI mice was statistically significant
(Po0.01) for the young adult cohort (Figure 4b, c). In a
small proportion of glomeruli from adult KI mice examined
at the ultrastructural level, ultrastructural changes character-
istic of collapsing glomerulopathy were observed, including
capillary collapse and wrinkling of the GBM, diffuse FP
effacement, loss of primary processes and cell simplification,
distension of Bowman’s space by cuboidal cells, and
accumulation of electron-dense lysosomes. In all of the
juvenile and adult KI mice in which podocyte injury was
present, a limited degree of actin condensation was noted
adjacent to the GBM. Basal actin condensation was always
focal, mild, and much less extensive than the degree of FP
effacement, with many effaced segments showing no actin
condensation.
Most KO mice (14 of 17) showed moderate-to-severe
GBM abnormalities (Figure 5i, j). The difference in mean
GBM abnormality score between WT and KO mice was
statistically significant for both juvenile (P¼ 0.01) and young
adult (Po0.01) cohorts (Figure 4a). Podocytes in nearly all
KO mice (16 of 17) exhibited degenerative changes similar to
those seen in KI mice (Figure 5i, j). The difference in both FP
and PCB abnormality scores between WT and KO mice was
statistically significant (Po0.01) for both juvenile and young
adult cohorts (Figure 4b, c). Glomerular ultrastructural
abnormalities in KO mice, although qualitatively similar to
KI mice, were characterized by more severe changes at an
earlier age, as compared to KI mice, and more frequently
included ultrastructural changes characteristic of collapsing
glomerulopathy (Figures 4 and 5g–j). One exception to this
pattern was the tendency for basal actin condensation in
injured podocytes to appear focal and mild, as in KI mice.
A unique ultrastructural finding seen primarily in KI mice
was the presence of cytoplasmic electron densities (Figures
5g, h and 6). These structures were seen in all KI mice
regardless of age or degree of podocyte injury. Almost all
HET mice (except two 4-week-old mice) demonstrated these
structures, with small but diffusely distributed electron
densities apparent in most adult HET mice. These structures
were also observed sporadically and more focally in older WT
mice, and focally in KO mice exhibiting concurrent severe
podocyte injury. These irregularly shaped, uniformly elec-
tron-dense structures ranged from 100 nm to greater than
1 mm in greatest dimension and were usually associated with
the cell membrane in podocyte cell bodies or major processes.
These structures were not observed in any other cell type
examined, including mesangial cells, endothelial cells, parietal
glomerular epithelium, vascular smooth muscle, tubular
epithelium, erythrocytes, platelets, and leukocytes.
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Figure 4 | Glomerular ultrastructural abnormality scores in
Actn4 transgenic mice. Mean scores for ultrastructural abnormalities
in (a) glomerular basement membranes (GBM), (b) podocyte
foot processes, and (c) podocyte cell bodies, scored from 0
(no abnormalities) to 4 (severe abnormalities). Data are distributed
into juvenile (0–7 weeks), young adult (7–21 weeks), and old adult
(421 weeks) age groups. Genotypes indicated by WT (wild type),
HET (heterozygous Actn4 K256E mutant), KI (homozygous Actn4
K256E mutant), and KO (homozygous Actn4 null). For each
category of ultrastructural abnormality, height of bars indicates mean
abnormality score (±s.d.) among all specimens examined within a
specified genotype and age group combination. Number of
specimens per age group-genotype combination (n) also indicated.
*Po0.05 vs WT.
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Immunogold transmission electron microscopy was per-
formed to better characterize the composition of these
electron-dense structures. Transmission electron micrographs
of immunogold-stained sections from juvenile and adult
KI mouse kidneys revealed high concentrations of actin and
a-actinin-4 together in these electron-dense structures in
podocytes (Figure 6). Lower concentrations of b-actin and
a-actinin-4 were also observed in podocyte FPs and the
cytoplasm of endothelial cells.
Immunohistochemistry
Kidneys from 18 mice (6 WT, 5 HET, 4 KI, and 3 KO), age
4.6–70.1 weeks, were examined and morphometrically evaluated
at the light microscopic level, using immunohistochemistry for
markers of podocyte injury, differentiation, and proliferation.
KI and KO mice exhibited an immunohistochemical phenotype
characteristic of collapsing glomerulopathy. In most KI mice
and all KO mice, morphometric analysis revealed loss of
expression of markers of podocyte differentiation, including
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Figure 5 | Glomerular ultrastructure in Actn4 transgenic mice. Representative transmitted electron photomicrographs of murine glomeruli
ages 4–60 weeks. Genotypes indicated by WT (wild type), HET (heterozygous Actn4 K256E mutant), KI (homozygous Actn4 K256E mutant), and
KO (homozygous Actn4 null). WT mice show no glomerular ultrastructural abnormalities at age 4 weeks (a) or 12 weeks (b); older WT mouse at
age 52 weeks (c) shows mild segmental glomerular basement membrane (GBM) thickening (arrowheads). Juvenile HET mouse at 4 weeks
(d) shows no glomerular ultrastructural abnormalities. Adult HET mice at 27 weeks (e) and 60 weeks (f) show segmental subepithelial GBM
thickening and redundancy (arrowheads), mild podocyte foot process (FP) degenerative changes including morphologic irregularity and
segmental effacement (small arrows), and mild microvillous degeneration of podocyte cell bodies (asterisks). Mild increase in cytoplasmic
organelles (endolysosomes) is also noted in podocyte cell body of 60-week HET animal (f). Juvenile (g) and young adult (h) KI mice at age 4 and
12 weeks, respectively, show segmental areas of GBM redundancy (arrowheads), podocyte FP degenerative changes including FP irregularity
and effacement (small arrows), and microvillous degeneration (asterisks). Changes are less prominent and segmental in 4-week KI mouse
(g), and more prominent and diffuse in 12-week KI mouse (h). Prominent and irregular intracytoplasmic electron densities (large arrows)
are also noted in podocyte cytoplasm of juvenile (g) and young adult (h) KI mice. Although features of podocyte injury were often apparent
in young adult KI mice, specific changes characteristic of collapsing glomerulopathy were focal and are not illustrated here. Juvenile KO mouse
at age 4 weeks (i) shows segmental GBM redundancy (arrowheads) and extensive podocyte FP effacement (small arrows); electron-dense
protein reabsorption granules (large arrows) are also noted in glomerular epithelial cells. Young adult KO mouse at age 10 weeks (j) shows
capillary collapse, GBM wrinkling and irregularity with focal redundancy (arrowheads), extensive podocyte FP effacement (small arrows),
podocyte cell body hypertrophy and distortion by large vacuoles (asterisks), and electron-dense protein reabsorption granules (large arrows).
Bar¼ 2 mm in all images.
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WT-1 and synaptopodin, and increased expression of desmin
(a marker of podocyte injury) in extracapillary glomerular
cells (Table 1, Figure 7). Additionally, all KI and KO mice
revealed increased expression of markers of proliferation,
including cyclin D1 and Ki-67 (Table 1, Figure 7). Although
one KI mouse (2373) did not exhibit loss of podocyte
markers WT-1 and synaptopodin, or evidence of podocyte
injury in the form of desmin staining, this mouse did show
increased staining for cyclin D1 and Ki-67 in podocytes,
suggesting early activation of proliferative mechanisms. In
contrast to the KI and KO mice, the staining pattern in HET
mice, including specimens as old as 60.1 and 70.1 weeks, was
comparable to that in WT mice (Table 1, Figure 7).
Endocapillary cells (endothelial cells and/or mesangial cells)
were weakly positive for cyclin D1 in all mice, as has been
reported previously by other investigators.5
DISCUSSION
These findings demonstrate that the homozygous a-actinin-4
K256E mutant (KI) and homozygous a-actinin-4 null (KO)
mice developed in our laboratory represent genetically new
and distinct models of collapsing glomerulopathy. Several
murine models of collapsing glomerulopathy have been
described, including transgenic animals exhibiting podocyte-
specific overexpression of vascular endothelial growth factor,6
podocyte expression of HIV (human immunodeficiency
virus) genes,7–9 and mitochondrial defects.5 Some of these
murine models also demonstrate a role for glomerular
epithelial proliferation in the pathogenesis of the character-
istic glomerular lesions, as in humans.5,9–11 In the Actn4 KO
and KI mice, collapsing glomerulopathy is associated with the
absence of WT a-actinin-4, a cytoskeletal protein. How might
the absence of WT a-actinin-4 precipitate collapsing
glomerulopathy? One possibility is that the collapsing lesion
may be a stereotypical response to certain forms of severe and
acute podocyte injury or loss. Work in our laboratory
suggests that the absence of a-actinin-4 may be associated
with increased podocyte shedding.12 Thus, lack of WT
a-actinin-4 protein may lead indirectly to the collapsing
phenotype, through a mechanism that promotes podocyte
detachment and loss.
Our results show considerable variability in the time
course of glomerular lesions in the KI and KO mice. For
instance, although almost all KO mice with glomerular
lesions exhibited collapsing lesions, a single juvenile KO
mouse (age 6.7 weeks) exhibited sclerosing lesions involving
most glomeruli, without morphologically distinctive collap-
sing lesions. At the other extreme, a small subset of KI and
KO animals in the 7- to 21-week cohort exhibited few or no
glomerular lesions. These findings suggest variability in the
rate of progression from ‘active’ collapsing lesions to
glomerulosclerosis. This phenotypic heterogeneity may be
secondary to genotypic variation in the mixed background
mice used for this study. Further studies with pure strains
may help to clarify the nature of this phenotypic variability.
Although the overall pattern of kidney damage observed
in the KI and KO mice was similar, there are two
distinguishing features. One consistent feature of our results
was the tendency for KO mice to show features of glomerular
injury that were more prominent and earlier appearing than
that observed in KI mice (Figures 1 and 4). This could be
accounted for by the presence of mutant a-actinin-4 in KI
mice, which may retain some of the function of WT a-
actinin-4. A second finding that distinguished the KI mice
from the other genotypes was the presence of prominent
intracytoplasmic electron densities in all KI mice. Similar but
smaller structures were also observed in almost all HET mice,
and although they generally remained small, they became
more diffusely distributed with age. These structures were
also observed sporadically and more focally in older WT
a
b
Figure 6 | Composition of intracytoplasmic electron densities
in homozygous Actn4 mutant (KI) mice. Immunogold transmission
electron microscopy of kidney from homozygous Actn4 K256E
mutant (KI) mouse at age 2 weeks showing labeling for b-actin
(10 nm gold particles) and a-actinin-4 (15 nm gold particles) within
intracytoplasmic electron densities. (a) Low-magnification image
shows cell membrane-associated intracytoplasmic electron densities
within podocyte cell body and extending into major process. High
concentrations of actin and a-actinin-4 are seen within electron
densities; lower concentrations of b-actin and a-actinin-4 are also
observed in podocyte foot processes, and in an endothelial cell on
the opposite side of the GBM at the bottom right of the image.
Bar¼ 500 nm. (b) High-magnification image confirms co-localization
of both b-actin and a-actinin-4 within intracytoplasmic electron
densities. Bar¼ 200 nm.
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mice, and sporadically in KO mice with severe podocyte
injury. Immunogold staining demonstrates that the aggre-
gates in KI mice contain both b-actin and (mutant)
a-actinin-4 (Figure 6). Work in our laboratory suggests that
mutant a-actinin-4 exhibits increased binding affinity
for actin.1,13 Therefore, these aggregates may represent
accumulations of bound actin and a-actinin-4 within the
cytoplasm resulting from increased actin binding, mediated
by mutant a-actinin-4.
In contrast to the KI and KO animals, the HET animals
did not develop overt glomerular lesions. However, there
were several minor findings noted in HET animals. Although
focal glomerulosclerosis was absent, a small proportion of
glomeruli in HET animals were hypertrophic at all ages
(Figures 1 and 2c, d). Mild ultrastructural abnormalities were
also noted in older HET mice, including mild FP abnorm-
alities and mild but diffuse electron-dense aggregate accu-
mulation (Figures 4 and 5f). In comparison, WT animals did
not exhibit the same degree of glomerular hypertrophy or
ultrastructural abnormalities as HET mice (Figures 1, 2a, b, 4,
and 5a–c). Although mild histologic and ultrastructural
changes are noted in the glomeruli of HET mice, immuno-
histochemistry in HET mice revealed a staining pattern
consistent with podocyte differentiation and comparable to
that observed in WT mice, even up to the age of 70.1 weeks
(Table 1). Thus, unlike KI and KO mice, the changes
developing with time in HET mice do not appear to involve
podocyte ‘de-differentiation.’ The mild glomerular changes
seen in HET mice may represent the cumulative effect of an
intrinsic cellular abnormality associated with the presence of
mutant a-actinin-4. The consistent finding of cytoplasmic
electron densities in older HET animals supports this.
Alternatively, the observed podocyte ultrastructural changes
may be an indirect result of other preceding functional
changes that lead to adaptive glomerular hypertrophy early in
life, and podocyte structural changes that are observable at
the ultrastructural level later on. Further studies, potentially
using podocyte-specific conditional transgenic animals, will
be required to clarify the nature of any functional deficit
associated with the Actn4 mutation.
Another transgenic mouse model exhibiting podocyte-
specific overexpression of K256E mutant a-actinin-4 protein
has been shown to develop features of podocyte injury and
focal glomerulosclerosis in a subset of proteinuric animals at
the age of 10 weeks.4 Why do these transgenic animals, with
heterozygous expression of mutant and WT Actn4, often
exhibit glomerular disease early in life, in contrast to our
HET animals? One key finding from the Michaud study is
that the relative expression level of mutant a-actinin-4 in
their mice correlated with the degree of proteinuria and
podocyte injury. In comparison, proteinuria was only
observed in a subset of our HET animals greater than 42
weeks of age (data not shown). This suggests that the HET
animals in our study may exhibit relatively low levels of
mutant Actn4 expression, in comparison with the proteinuric
transgenic animals of Michaud et al. The development of a
mutant-specific antibody that might be useful for the direct
quantification of protein expression levels in our HET
Table 1 | Proportion of glomeruli in Actn4 transgenic mice exhibiting immunohistochemical phenotypic alterations
characteristic of collapsing glomerulopathy
Mouse Age (weeks) Genotype
WT-1
(% negative)
Synaptopodin
(% negative)
Desmin
(% positive)
Cyclin D1
(% positive)
Ki-67
(% positive)
2485 10 WT 1.3 0.0 1.7 7.8 8.0
2486 10 WT 2.0 0.0 0.0 3.6 10.8
2372 12.7 WT 2.0 0.0 0.0 2.5 4.4
1652 18.4 WT 6.3 2.9 2.6 3.0 14.4
1826 60.1 WT 5.8 1.5 3.1 3.5 10.7
1571 70.1 WT 2.5 2.1 0.0 5.0 9.8
2370 12.7 HET 5.6 0.0 3.7 7.4 1.4
8970 13.1 HET 9.7 6.4 1.3 7.7 8.0
1651 18.4 HET 3.8 2.5 3.2 5.6 10.3
1825 60.1 HET 9.0 3.9 3.2 4.9 13.9
1572 70.1 HET 4.1 0.9 1.4 3.8 10.5
2371 12.7 KI 31.2 54.2 38.6 30.6 47.0
2373 12.7 KI 5.8 6.0 5.7 21.5 26.1
8971 13.1 KI 52.5 41.7 51.9 56.5 42.5
1649 18.4 KI 76.8 33.3 46.6 30.1 12.5
2303 4.6 KO 31.6 27.6 42.9 42.2 43.1
2484 10 KO 10.0 24.5 50.3 47.1 56.8
2488 10 KO 30.4 38.3 42.0 48.5 24.1
HET, heterozygous Actn4 K256E mutant mice; KI, homozygous Actn4 K256E mutant mice; KO, homozygous Actn4 null mice; WT, wild-type mice.
Glomeruli were considered to demonstrate an altered podocyte phenotype if they exhibited desmin in at least one glomerular segment, cyclin D1 or Ki-67 in one or more
extracapillary (that is podocyte) cell nuclei in the glomerular tuft, absence of WT-1 in extracapillary nuclei of at least one glomerular segment, or absence of synaptopodin
throughout the glomerulus. Endocapillary (that is, mesangial or endothelial) cell staining for desmin, cyclin D1, or Ki-67 was not considered to represent an altered podocyte
phenotype. No fewer than 40 glomeruli were counted in any section.
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animals is essentially impossible, as there is only a single
amino acid difference between WT and mutant a-actinin-4.
Therefore it is not possible to compare expression of mutant
and WT protein directly. Another important difference
between these animal models involves control of gene
expression. In the heterozygous mutant (HET) mice we
describe, both the mutant and WT alleles are under the
control of the endogenous promoter. In the transgenic model
that Michaud described, mutant Actn4 expression is under
the control of a podocyte-specific promoter. In these mice,
both of the normal WT Actn4 alleles remain intact. Thus,
there are important differences in the number of copies of
both the mutant and WT alleles in these models and in the
way that the expression of the mutant alleles is regulated. It
seems very likely that these differences will result in
differences in quantities of expressed protein and in the
temporal pattern and degree of variability of protein
expression. Indeed, the Michaud paper reported a good deal
of variability in the phenotype of the transgenic mice derived
from different founders.
GBM abnormalities were observed as a feature of aging in
all genotypes, but were more prominent in KI and KO mice,
and tended to correlate with the extent of podocyte injury
(Figures 4 and 5). Distinct structures composed of redundant
GBM were often seen protruding from the subepithelial
surface, and the podocyte processes overlying these structures
almost always exhibited loss of FP organization. Similar
structures have been described in another transgenic mouse
model that exhibits podocyte alterations.14 The presence of
FP disorganization in areas where GBM abnormalities occur
WT-1
WT
HET
KI
KO
Synaptopodin Desmin Cyclin D1 Ki-67
Figure 7 | Immunohistochemical phenotype of podocytes in Actn4 transgenic mice. Immunohistochemical staining for WT-1, a marker
of podocyte differentiation, reveals global nuclear staining in extracapillary cells in glomeruli of WT and HET mice, and marked absence
of WT-1 staining in glomeruli of KI and KO mice that exhibit collapsing lesions (first column). Synaptopodin, another marker of podocyte
differentiation, is globally positive in a peripheral capillary wall distribution in the glomeruli of WT mice, and is also globally positive but
less intense in HET mice (second column). Synaptopodin staining is absent in glomeruli of KI and KO mice that exhibit collapsing lesions.
Desmin, a marker of podocyte injury, is absent in glomeruli of WT and HET mice, but is segmentally positive in podocytes in lesional glomeruli
of KI and KO mice (third column). Cyclin D1 (fourth column) and Ki-67 (fifth column), markers of cell cycle engagement, are negative in
extracapillary glomerular cells in WT and HET mice, but show strong nuclear positivity in a subset of extracapillary cells (podocytes) of
lesional glomeruli in KI and KO mice. Endocapillary cells (endothelial and/or mesangial cells) in all mice normally exhibit weak positivity
for cyclin D1. Original magnification  625 in WT and HET images and  500 in KI and KO images.
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in KI and KO mice suggests that the GBM abnormalities may
be a manifestation of podocyte injury, perhaps indicating
areas where loss of FP organization has resulted in the uneven
deposition of basement membrane material. Thus, although
these structures may arise with time in all mice, it is
conceivable that they might occur with increased frequency
in animals with overt and widespread podocyte injury, such
as our KI and KO mice.
As the HET mice represent the most faithful genetic model
of ACTN4-mediated human disease, it is of interest to
compare the morphologic findings in the HET mice with
those seen in the kidneys of humans with ACTN4 mutations.
Four biopsies from humans who carried ACTN4 mutations
and exhibited clinical evidence of kidney disease were
available for our examination. In contrast to the HET mice,
all four human kidneys show focal-to-extensive global and
segmental glomerulosclerosis, mild-to-moderate chronic
tubulointerstitial damage, and segmental podocyte injury
(FP effacement, microvillous change and so on). However,
there are some common findings in the murine and human
mutant kidneys. One similarity is the presence of mild
alterations of the GBM, seen in all human biopsies, consisting
of segmental redundancy of the lamina densa (that is, ‘double
contours’). The second similarity is the presence of mild-to-
extensive accumulation of intracytoplasmic electron densities
in all four of the human biopsies, which were morphologi-
cally identical to those seen in the transgenic mice. As with
the mice, the extent of involvement was variable, with the
most prominent aggregates observed in a patient with
morphologically mild disease. To our knowledge, such
structures have not been reported in human collapsing
glomerulopathy, or in other forms of podocyte injury. A third
similarity was the presence of focal glomerular hypertrophy
in three of four human cases. This finding was most
pronounced in two patients with moderate chronic damage.
Of the two remaining patients, both of whom exhibited mild
(and presumably early) kidney damage, one patient also
showed focal glomerular hypertrophy, whereas the other did
not. In the two patients with more advanced chronic damage,
the glomerular hypertrophy may represent a secondary
compensatory response to loss of functional renal mass. It
would be necessary to examine kidney tissue from these
patients earlier in the disease course to determine whether
focal glomerular hypertrophy is present in the intact kidney,
as is the case in the HET mice. Nevertheless, these similar
findings are consistent with the notion that the human
disease pathology observed represents further progression of
the same mechanism operating in the murine HET model.
In humans who carry ACTN4 mutations, functional
glomerular disease is rarely observed before early adulthood,
and there is considerable variability in the age of onset and
penetrance of glomerular disease.1 Thus, additional mod-
ulating factors (genetic or otherwise) appear to play a role in
the development of ACTN4-mediated human disease. Overt
glomerular disease does not develop spontaneously in HET
mice up to at least 2 years of age, suggesting the absence of
necessary modifying factors in the laboratory animal.
The findings of Michaud et al. suggest that variability in
expression levels of mutant ACTN4 could contribute to
phenotypic heterogeneity in Actn4 transgenic mouse models,
and correspondingly in humans.4 Currently, specific genetic
modifiers of human ACTN4-mediated disease have not been
conclusively identified. However, if such factors are identified
in the future, it may be possible to study their effect using the
HET animal. Similarly, environmental, behavioral, or phy-
siologic factors, such as hypertension or diet, may be studied
in the HET mouse. Further studies such as these may show
that additional ‘stressors’ are required to precipitate overt
kidney disease in heterozygous Actn4 mutant mice.
In summary, our findings show that genetic defects
affecting a single cytoskeletal protein, a-actinin-4, can cause
different morphologic patterns of injury, depending upon the
nature of the genetic defect. Further study of the mechanism
by which Actn4 deficiency leads to podocyte injury and
glomerular collapse, and comparison with other models of
glomerular collapse, will help to better define the basis of this
lesion. Our findings also suggest that additional modifying
factors play a role in the development of glomerular disease
in the heterozygous Actn4 mutant animal. This may account
for phenotypic variability seen in human ACTN4-mediated
disease. Subsequent studies will be required to identify these
modifying factors, and Actn4 transgenic animal models will
play an important role in that process.
MATERIALS AND METHODS
Mice
Previously, we described the development of genetically distinct
Actn4 K256E mutant and Actn4 null transgenic strains.2,3 Both of
these strains, bred on a mixed 129/SvJ and C57BL/6 genetic
background, were used for these studies. A total of 123 mice were
examined. Mice were genotyped using PCR amplification of DNA
isolated from mouse tails.3
Tissue collection
All experimental procedures were performed in accordance with the
guidelines of the Institutional Animal Care and Use Committee at
Harvard University. Transgenic mice exhibiting any of the four
genotypes including WT, HET, KI, and KO were killed at various
ages from 1 to 93 weeks, so as to obtain an evenly distributed age
representation of each genotype across the life cycle. Sampling was
more concentrated in the juvenile (0–7 weeks) and young adult
(7–21 weeks) age ranges, where all the four genotypes were represented
(KI and KO mice did not survive beyond 21 weeks), and where the
most dramatic and rapidly evolving changes were noted. Kidneys were
harvested, divided, and placed in formalin, Bouin’s and Karnovsky’s
fixatives for light and electron microscopy. Selected specimens retained
for immunogold studies were fixed in paraformaldehyde/lysine/
periodate fixative according to standard protocol.
Light microscopy
Fixed kidney tissue was paraffin-processed, and 4 mm sections were
stained with hematoxylin and eosin and periodic acid Schiff stains.
Light microscopic evaluation included quantification of the total
number of glomeruli present in one microscopic section as well as
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quantification of lesional glomeruli (global sclerosis, segmental
sclerosis, glomerular collapse, and glomerular hypertrophy).
Glomerular size (that is, normal vs hypertrophic glomeruli) was
evaluated subjectively. The tubulointerstitial and vascular compart-
ments were also evaluated.
Electron microscopy
Fixed specimens of kidney cortex were trimmed into small
fragments, post-fixed with osmium tetroxide, dehydrated in serial
ethanols, and embedded in epoxy resin. Semi-thin sections were cut at
1mm and stained with toluidine blue for light microscopic examina-
tion. Ultrathin sections were cut at 80 nm, mounted on 200 mesh
copper grids, treated with uranyl acetate and lead citrate, and examined
in a JEOL 1010 transmission electron microscope (Tokyo, Japan).
Electron micrographs showing glomerular ultrastructure ( 500
to  50 000) were collected and evaluated in a blinded manner by
two kidney pathologists (JMH and SA) At least three mature
glomeruli from the deep cortex were evaluated in each specimen.
For each specimen, scores were assigned from 0 (no abnormality) to
4 (severe abnormality) for two categories of ultrastructural changes
indicating podocyte injury, including abnormalities of the PCB,
such as microvillous degeneration, vacuolization, and increased
number of cytoplasmic organelles; and abnormalities of the
podocyte FP, including effacement and morphologic irregularity.
GBM abnormalities were also scored for each specimen in a similar
manner, as a third category of ultrastructural changes. Within each
age group, differences between mean scores for WT and other
genotypes were compared using Student’s t-test, assuming unequal
variances. Other ultrastructural changes in the podocyte, including
actin condensation at the basal FPs, and the presence of cytoplasmic
electron-dense aggregates, were assessed non-quantitatively.
Immunohistochemistry
Formalin-fixed mouse kidney tissue was paraffin-processed and
sectioned at 4 mm. After processing for antigen retrieval, sections
were treated with antibodies against WT-1 (clone 6F-H2),
synaptopodin (mouse monoclonal, gift of Dr Peter Mundel, Mount
Sinai School of Medicine, New York, NY, USA), desmin (clone D33;
Dako, Carpenteria, CA, USA), cyclin D1 (clone SP4; Abcam,
Cambridge, MA, USA), or Ki-67 (polyclonal; Vector, Burlingame,
CA, USA), followed by treatment with biotinylated secondary
antibody and avidin-biotin complexes (Vectastain Elite ABC Kit;
Vector Laboratories). All sections were counterstained with
hematoxylin. Immunohistochemical phenotype was evaluated by
determining the proportion of glomeruli in the section exhibiting
the altered podocyte phenotype characteristic of collapsing glomer-
ulopathy. Glomeruli were considered to exhibit an altered podocyte
phenotype if they exhibited desmin in at least one glomerular
segment, cyclin D1 or Ki-67 in one or more extracapillary (that is,
podocyte) cell nuclei in the glomerular tuft, absence of WT-1 in
extracapillary nuclei of at least one glomerular segment, or absence
of synaptopodin throughout the glomerulus. Endocapillary (that is,
mesangial or endothelial) cell staining for desmin, cyclin D1, or
Ki-67 was not considered to represent an altered podocyte phenotype.
No fewer than 40 glomeruli were counted in any section.
Immunogold electron microscopy
Mouse kidney tissue retained for immunogold electron microscopy
was trimmed, dehydrated in serial ethanols, and embedded in LR
White resin (EMS, Hatfield, PA, USA). Ultrathin sections were cut at
90 nm and collected on formvar-coated grids. Sections were blocked
for 10 min with 5% normal goat serum (Sigma, St Louis, MO, USA)
and incubated for 1 h on anti-b-actin (Sigma) or anti-a-actinin-4 (gift
of A Beggs) diluted in Dako diluent. Antibodies were labeled with goat
anti-mouse/anti-rabbit IgG gold, 10 nm and 15 nm, respectively (Ted
Pella, Redding, CA, USA) in Dako diluent for 1 h. Grids were stained
with 2% aqueous uranyl acetate for 10 min, rinsed, and air dried.
Sections were examined and digital photomicrographs recorded using a
JEOL 1011 transmission electron microscope.
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